Home > Online Clinic News > New Herpes Suppression Study Published

Latest News

by Marijana Domazet, Monday, 01 April 2013 | Categories: Sexual Health

New research from the Albert Einstein College of Medicine has identified a key mechanism that plays a part in the proliferation of herpes viruses in human cells. The findings, which were published in The FASEB Journal, could be useful for developing novel approaches in the treatment of herpes.

The study in question was an observational study that examined how laboratory cultures of human cells would react to herpes exposure to herpes simplex virus 2 if they had been pre-treated with medications that contained Akt inhibitors. It is worth mentioning that Akt is a signalling molecule known to play part in many stages of a cell’s course, including apoptosis (cell death).  In the study, the researchers either exposed the sample to one of four different treatments known to inhibit Akt or did not expose the sample to any treatment. This lasted 15 minutes. In the next stage, the cells got exposure to herpes simplex virus 2. This lasted 60 minutes. The key findings indicated that all the cells that had been treated with Akt inhibiting medications had a significantly lower herpes virus infection regardless of the type of cells that had been exposed to the virus. Conversely, cells that had not been treated with Akt inhibitors had been more easily infected by exposure to herpes simplex 2 virus. This led the researchers to conclude that treatments suppressing Akt could be useful for suppressing herpes infections among individuals that have already got the virus.

Although this study presents novel findings, the rationale for it being conducted in the first place is logical when put into context. Specifically, it is worth noting that this study further supports a previous study by the same team, which found that the release of calcium in cells affected the infection by the herpes simplex virus 2. However, we are not aware of similar studies being conducted by other teams that would further corroborate these findings. Similarly, it is too early to see the potential long-term effects this treatment would have. Nevertheless, given the life-long effects a herpes simplex 2 infection brings with it, we are glad to hear that the area is given its due attention from researchers. Further details of this study can be read at The Journal of the Federation of American Societies of Experimental Biology.





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close